American Century Companies’s Novo Nordisk NVO Stock Holding History

American Century Companies's NVO Position: Q2 2026 in Review

American Century Companies increased its Novo Nordisk (NVO) stake by 20% in Q2 2026, buying an estimated $10.5M and bringing the position to 1,455,351 shares worth $69.8M. The position accounts for 0.03% of the portfolio, ranked #693.

American Century Companies first reported a position in NVO in Q3 2014 and has held it in 28 quarters since. The position peaked at $204M in Q2 2024. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

• American Century Companies held 1,455,351 shares of Novo Nordisk worth $69.8M as of Q2 2026.
• American Century Companies bought 244,032 Novo Nordisk shares in Q2 2026, an estimated $10.5M.
• Novo Nordisk made up 0.03% of American Century Companies's portfolio in Q2 2026, its #693 holding.
• American Century Companies first reported a position in Novo Nordisk in Q3 2014 and has held it in 28 quarters since.
• American Century Companies's Novo Nordisk position peaked at $204M in Q2 2024.
• 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on American Century Companies's 13F filing for Q2 2026, filed 12 Aug 2026.